Two Studies Show Doxy PEP is a Winning Strategy
Two studies published in this month’s JAMA Internal Medicine offer encouraging findings about the use of Doxy PEP.
NGU, or Nongonoccocal Urethritis
Nongonococcal urethritis—or NGU—is an infection of the urethra caused by germs other than gonorrhea. The most common cause is chlamydia.
New CDC Guidelines Offer Recommendations On Doxy PEP
Doxy PEP involves taking an oral antibiotic after condomless sex to prevent bacterial STIs. Research has shown that this can reduce the possibility of contracting chlamydia by 88%, syphilis by 87%, and gonorrhea by 55%.
Doxy PEP is a New Strategy to Help Prevent STIs
Doxy PEP is the strategy of taking the antibiotic doxycycline after condomless oral or anal sex to prevent chlamydia, gonorrhea, or syphilis.
New Studies Add to Evidence that Doxy PEP Works for STI Prevention
New studies add to our evidence that doxy PEP is working to prevent bacterial STIs among transgender women and men who have sex with men.
PID is a leading cause of infertility in women
Pelvic Inflammatory Disease (PID) Pelvic inflammatory disease (PID) is a serious infection in the upper genital tract/reproductive organs (uterus, fallopian tubes and ovaries) of women. PID can be sexually transmitted or naturally occurring. It can lead to infertility in women (unable to have children) or life-threatening complications. Women between ages 15 and 25 have the […]
The State of STIs — CDC Reports an Startling Rise in Syphilis
CDC released new surveillance data on sexually transmitted infections. There were 2.5 million cases of chlamydia, gonorrhea, and syphilis reported in the United States in 2022. Most alarming was a rise in syphilis rates, up 80% since 2018.
New Antibiotic Shows Promise in Treating Resistant Gonorrhea
A new antibiotic could give health care providers a much-needed new tool in the fight against antibiotic resistant strains of gonorrhea.
